Mega Lifesciences PCL (BKK:MEGA)
Thailand · Delayed Price · Currency is THB 39.75
+0.75 (1.92%)
Feb 10, 2026, 4:36 PM ICT
Mega Lifesciences PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,974 | 2,012 | 1,993 | 2,242 | 1,947 | 1,393 |
Depreciation & Amortization | 278.98 | 277.74 | 279.98 | 265.18 | 268.86 | 250.98 |
Other Amortization | 5.69 | 5.69 | 5.89 | 6.83 | 5.57 | 5.35 |
Loss (Gain) From Sale of Assets | -5.02 | -2.65 | -2.87 | -2.08 | -3.51 | 0.51 |
Asset Writedown & Restructuring Costs | -0.66 | -0.59 | -0.54 | 8.59 | 28.02 | - |
Loss (Gain) on Equity Investments | 0.25 | -0.15 | -0.07 | -0.18 | 1.51 | 45.52 |
Provision & Write-off of Bad Debts | 2.61 | 3.68 | 12.17 | 5.83 | 3.09 | 2.18 |
Other Operating Activities | 157.95 | 251.64 | 238.72 | 70.4 | 39.8 | 127.31 |
Change in Accounts Receivable | -136.41 | 231.3 | -322.23 | -631.47 | 18.02 | 68.51 |
Change in Inventory | 32.64 | 447.19 | 569.37 | -576.69 | -273.63 | -602.17 |
Change in Accounts Payable | -63.64 | -278.66 | -885.27 | 364.68 | 375.68 | 48.44 |
Change in Other Net Operating Assets | 267.98 | -546.28 | 38.65 | 243.99 | 316.59 | 290.15 |
Operating Cash Flow | 2,515 | 2,401 | 1,926 | 1,997 | 2,727 | 1,629 |
Operating Cash Flow Growth | 27.90% | 24.65% | -3.51% | -26.78% | 67.35% | 8.98% |
Capital Expenditures | -485.14 | -247.53 | -274.65 | -304.6 | -151.4 | -234.43 |
Sale of Property, Plant & Equipment | 4.07 | 17.72 | 4.53 | 2.86 | 6.47 | 4.04 |
Cash Acquisitions | - | - | - | -9.25 | - | -410.56 |
Sale (Purchase) of Intangibles | -8.39 | -9.76 | -18.93 | -8.14 | -8.38 | -20.64 |
Investment in Securities | -344.81 | 178.14 | -20.11 | -1.75 | -122.57 | 0.62 |
Other Investing Activities | 64.97 | 62.87 | 59.14 | 40.07 | 11.19 | 10.68 |
Investing Cash Flow | -769.29 | 1.45 | -250.01 | -280.83 | -264.68 | -650.28 |
Short-Term Debt Issued | - | 215.37 | - | 65.2 | - | - |
Total Debt Issued | 282.27 | 215.37 | - | 65.2 | - | - |
Short-Term Debt Repaid | - | - | -148.66 | - | -309.49 | -432.03 |
Long-Term Debt Repaid | - | -60.16 | -88.6 | -58.1 | -53.52 | -55.54 |
Total Debt Repaid | -62.58 | -60.16 | -237.26 | -58.1 | -363.01 | -487.57 |
Net Debt Issued (Repaid) | 219.69 | 155.21 | -237.26 | 7.1 | -363.01 | -487.57 |
Common Dividends Paid | -1,395 | -1,395 | -1,439 | -1,406 | -922.94 | -670.19 |
Other Financing Activities | -46.95 | -38.04 | -31.75 | -34.76 | -27.93 | -64.63 |
Financing Cash Flow | -1,222 | -1,277 | -1,708 | -1,433 | -1,314 | -1,222 |
Foreign Exchange Rate Adjustments | -9.63 | -19.42 | -64.92 | -26.76 | 42.98 | 1.77 |
Net Cash Flow | 513.97 | 1,106 | -96.74 | 255.77 | 1,191 | -241.47 |
Free Cash Flow | 2,030 | 2,154 | 1,652 | 1,692 | 2,575 | 1,395 |
Free Cash Flow Growth | 19.23% | 30.39% | -2.38% | -34.30% | 84.62% | 44.32% |
Free Cash Flow Margin | 14.30% | 14.00% | 10.51% | 10.76% | 18.17% | 11.06% |
Free Cash Flow Per Share | 2.33 | 2.47 | 1.90 | 1.94 | 2.95 | 1.60 |
Cash Interest Paid | 46.95 | 38.04 | 31.75 | 29.85 | 27.93 | 64.63 |
Cash Income Tax Paid | 385.89 | 362.3 | 423.09 | 389.5 | 362.76 | 227.43 |
Levered Free Cash Flow | 2,043 | 2,289 | 1,413 | 1,209 | 1,989 | 864.17 |
Unlevered Free Cash Flow | 2,075 | 2,314 | 1,433 | 1,227 | 2,006 | 909.34 |
Change in Working Capital | 100.56 | -146.45 | -599.47 | -599.49 | 436.66 | -195.08 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.